Literature DB >> 21270129

Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury.

Marion Hölscher1, Monique Silter, Sabine Krull, Melanie von Ahlen, Amke Hesse, Peter Schwartz, Ben Wielockx, Georg Breier, Dörthe M Katschinski, Anke Zieseniss.   

Abstract

Prolylhydroxylase domain proteins (PHD) are cellular oxygen-sensing molecules that regulate the stability of the α-subunit of the transcription factor hypoxia inducible factor (HIF)-1. HIF-1 affects cardiac development as well as adaptation of the heart toward increased pressure overload or myocardial infarction. We have disrupted PHD2 in cardiomyocytes (cPhd (-/-)) using Phd2(flox/flox) mice in combination with MLCvCre mice, which resulted in HIF-1α stabilization and activation of HIF target genes in the heart. Although cPhd2(-/-) mice showed no gross abnormalities in cardiac filament structure or function, we observed a significant increased cardiac capillary area in those mice. cPhd2 (-/-) mice did not respond differently to increased mechanical load by transverse aortic constriction compared with their wild-type (wt) littermates. After ligation of the left anterior descending artery, however, the area at risk and area of necrosis were significantly smaller in the cPhd2(-/-) mice compared with Phd2 wt mice in line with the described pivotal role of HIF-1α for tissue protection in case of myocardial infarction. This correlated with a decreased number of apoptotic cells in the infarcted myocardium in the cPhd2(-/-) mice and significantly improved cardiac function 3 weeks after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270129      PMCID: PMC3064173          DOI: 10.1074/jbc.M110.186809

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart.

Authors:  Yan Huang; Reed P Hickey; Jennifer L Yeh; Dinggang Liu; Agnes Dadak; Lawrence H Young; Randall S Johnson; Frank J Giordano
Journal:  FASEB J       Date:  2004-05-07       Impact factor: 5.191

2.  Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse.

Authors:  Masakuni Kido; Lingling Du; Christopher C Sullivan; Xiaodong Li; Reena Deutsch; Stuart W Jamieson; Patricia A Thistlethwaite
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

3.  Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system.

Authors:  Daniel P Stiehl; Renato Wirthner; Jens Köditz; Patrick Spielmann; Gieri Camenisch; Roland H Wenger
Journal:  J Biol Chem       Date:  2006-06-21       Impact factor: 5.157

4.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  A conserved family of prolyl-4-hydroxylases that modify HIF.

Authors:  R K Bruick; S L McKnight
Journal:  Science       Date:  2001-10-11       Impact factor: 47.728

6.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

7.  Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury.

Authors:  Jaana Hyvärinen; Ilmo E Hassinen; Raija Sormunen; Joni M Mäki; Kari I Kivirikko; Peppi Koivunen; Johanna Myllyharju
Journal:  J Biol Chem       Date:  2010-02-25       Impact factor: 5.157

Review 8.  Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.

Authors:  A Palazzuoli; M Gallotta; I Quatrini; R Nuti
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

9.  Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.

Authors:  Kotaro Takeda; Ann Cowan; Guo-Hua Fong
Journal:  Circulation       Date:  2007-07-23       Impact factor: 29.690

Review 10.  Signalling hypoxia by HIF hydroxylases.

Authors:  Christopher J Schofield; Peter J Ratcliffe
Journal:  Biochem Biophys Res Commun       Date:  2005-08-24       Impact factor: 3.575

View more
  32 in total

Review 1.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

Review 2.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

3.  Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury.

Authors:  Pinelopi P Kapitsinou; Jonathan Jaffe; Mark Michael; Christina E Swan; Kevin J Duffy; Connie L Erickson-Miller; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-18

4.  Hematological, hepatic, and retinal phenotypes in mice deficient for prolyl hydroxylase domain proteins in the liver.

Authors:  Li-Juan Duan; Kotaro Takeda; Guo-Hua Fong
Journal:  Am J Pathol       Date:  2014-02-06       Impact factor: 4.307

5.  PHD2/3-dependent hydroxylation tunes cardiac response to β-adrenergic stress via phospholamban.

Authors:  Liang Xie; Xinchun Pi; W H Davin Townley-Tilson; Na Li; Xander H T Wehrens; Mark L Entman; George E Taffet; Ashutosh Mishra; Junmin Peng; Jonathan C Schisler; Gerhard Meissner; Cam Patterson
Journal:  J Clin Invest       Date:  2015-06-15       Impact factor: 14.808

Review 6.  Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics?

Authors:  Saravanan S Karuppagounder; Rajiv R Ratan
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-14       Impact factor: 6.200

Review 7.  The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.

Authors:  William G Kaelin
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

8.  Activation of hypoxia response in endothelial cells contributes to ischemic cardioprotection.

Authors:  Risto Kerkelä; Sara Karsikas; Zoltan Szabo; Raisa Serpi; Johanna Magga; Erhe Gao; Kari Alitalo; Andrey Anisimov; Raija Sormunen; Ilkka Pietilä; Laura Vainio; Walter J Koch; Kari I Kivirikko; Johanna Myllyharju; Peppi Koivunen
Journal:  Mol Cell Biol       Date:  2013-06-17       Impact factor: 4.272

9.  Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium.

Authors:  Wei Eric Wang; Dezhong Yang; Liangpeng Li; Wei Wang; Yulan Peng; Caiyu Chen; Peng Chen; Xuewei Xia; Hongyong Wang; Jiahui Jiang; Qiao Liao; Yuan Li; Ganfeng Xie; Haiyun Huang; Yanli Guo; Linda Ye; Dayue Darrel Duan; Xiongwen Chen; Steven R Houser; Chunyu Zeng
Journal:  Circ Res       Date:  2013-05-21       Impact factor: 17.367

10.  HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury.

Authors:  Sara Karsikas; Mikko Myllymäki; Minna Heikkilä; Raija Sormunen; Kari I Kivirikko; Johanna Myllyharju; Raisa Serpi; Peppi Koivunen
Journal:  J Mol Med (Berl)       Date:  2015-10-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.